Jeffrey Linton - Nextgen Healthcare President
| NXGNDelisted Stock | USD 16.53 0.05 0.30% |
President
Mr. Jeffrey D. Linton is Executive Vice President, General Counsel, Secretary of the company. Prior to joining the Company, Mr. Linton, age 54, served from November 2016 to November 2017 as General Counsel and Secretary of Applied Proteomics, Inc., a company that develops noninvasive, bloodbased tests for monitoring and early detection of disease, where he was responsible for all legal, intellectual property, compliance, and human resources activities. Previously, Mr. Linton was Senior Vice President, General Counsel and Secretary of Sequenom, Inc., a life sciences company, from September 2014 to October 2016. Before joining Sequenom, Mr. Linton served as Senior Vice President and General Counsel at Beckman Coulter, Inc., a biomedical testing products company, from July 2011 to September 2014. He previously served in various roles with Serologicals Corporationrationration, a company that developed, manufactured and sold life science research products and technologies, diagnostic kits and drug discovery services. His prior experience also includes various other positions in law, government and public affairs and human resources since 2017.
| Age | 60 |
| Tenure | 8 years |
| Phone | 404 467 1500 |
| Web | https://www.nextgen.com |
Nextgen Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.038 % which means that it generated a profit of $0.038 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0144) %, meaning that it created substantial loss on money invested by shareholders. Nextgen Healthcare's management efficiency ratios could be used to measure how well Nextgen Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Nextgen Healthcare currently holds 274.76 M in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. Nextgen Healthcare has a current ratio of 1.26, suggesting that it may not be capable to disburse its financial obligations when due. Note, when we think about Nextgen Healthcare's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 13 records | PRESIDENT Age | ||
| Jonathan Maack | Definitive Healthcare Corp | 45 | |
| Leif Pedersen | Certara | 61 | |
| Edward Pearson | HealthStream | 61 | |
| Trisha Coady | HealthStream | 48 | |
| Patrick PharmD | Certara | 54 | |
| Michael Sousa | HealthStream | 56 | |
| Robert Aspbury | Certara | 53 | |
| Larry Trittschuh | HealthEquity | 52 | |
| Angelique Hill | HealthEquity | 55 | |
| Mollie Condra | HealthStream | N/A | |
| Delano Ladd | HealthEquity | 43 | |
| Jeffrey Cunningham | HealthStream | 58 | |
| Michael Collier | HealthStream | 48 | |
Management Performance
| Return On Equity | -0.0144 | |||
| Return On Asset | 0.038 |
Nextgen Healthcare Leadership Team
Elected by the shareholders, the Nextgen Healthcare's board of directors comprises two types of representatives: Nextgen Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nextgen. The board's role is to monitor Nextgen Healthcare's management team and ensure that shareholders' interests are well served. Nextgen Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nextgen Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Srinivas Velamoor, Chief VP | ||
| David Metcalfe, Executive Vice President CTO | ||
| David Ahmadzai, Corp VP | ||
| David Slazyk, Chief Officer | ||
| Colleen Edwards, VP Marketing | ||
| Mitchell Waters, Ex Growth | ||
| David Sides, Pres CEO | ||
| James Arnold, CFO, Executive Vice President | ||
| Jeffrey Linton, Executive Vice President General Counsel, Secretary | ||
| Matthew Scalo, VP Relations |
Nextgen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nextgen Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0144 | |||
| Return On Asset | 0.038 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 1.68 B | |||
| Shares Outstanding | 67.1 M | |||
| Shares Owned By Insiders | 33.55 % | |||
| Shares Owned By Institutions | 81.43 % | |||
| Number Of Shares Shorted | 4.84 M | |||
| Price To Earning | 253.66 X |
Pair Trading with Nextgen Healthcare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nextgen Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nextgen Healthcare will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Nextgen Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nextgen Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nextgen Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nextgen Healthcare to buy it.
The correlation of Nextgen Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nextgen Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nextgen Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nextgen Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Nextgen Stock
If you are still planning to invest in Nextgen Healthcare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nextgen Healthcare's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |